These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 23373961)
1. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma. Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Implications of Lymph Node Yield in Central and Lateral Neck Dissections for Well-Differentiated Papillary Thyroid Carcinoma. Heaton CM; Chang JL; Orloff LA Thyroid; 2016 Mar; 26(3):434-40. PubMed ID: 26825749 [TBL] [Abstract][Full Text] [Related]
3. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio. Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274 [TBL] [Abstract][Full Text] [Related]
5. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma. Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096 [TBL] [Abstract][Full Text] [Related]
6. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer. Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509 [TBL] [Abstract][Full Text] [Related]
7. The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma. Hu JQ; Wen D; Ma B; Zhang TT; Liao T; Shi X; Wang YL; Zhu YX; Wang Y; Wei WJ; Ji QH Cancer Med; 2020 Feb; 9(3):1017-1024. PubMed ID: 31854077 [TBL] [Abstract][Full Text] [Related]
8. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study. Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Wu MH; Shen WT; Gosnell J; Duh QY Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456 [TBL] [Abstract][Full Text] [Related]
11. Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study. Yu ST; Ge JN; Sun BH; Wei ZG; Xiao ZZ; Zhang ZC; Chen WS; Li TT; Lei ST Oral Oncol; 2021 Dec; 123():105567. PubMed ID: 34710736 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting the adequacy of lymph node yield in prophylactic unilateral central neck dissection for papillary thyroid carcinoma. Lang BH; Yih PC; Shek TW; Wan KY; Wong KP; Lo CY J Surg Oncol; 2012 Dec; 106(8):966-71. PubMed ID: 22718439 [TBL] [Abstract][Full Text] [Related]
13. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence. Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306 [TBL] [Abstract][Full Text] [Related]
14. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis. Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863 [TBL] [Abstract][Full Text] [Related]
15. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer. Barczyński M; Konturek A; Stopa M; Nowak W Langenbecks Arch Surg; 2014 Feb; 399(2):237-44. PubMed ID: 24213969 [TBL] [Abstract][Full Text] [Related]
16. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma. Hong YR; Lee SH; Lim DJ; Kim MH; Jung CK; Chae BJ; Song BJ; Bae JS World J Surg Oncol; 2017 Apr; 15(1):74. PubMed ID: 28376807 [TBL] [Abstract][Full Text] [Related]
17. A Retrospective Study of Lymph Node Yield in Lateral Neck Dissection for Papillary Thyroid Carcinoma. Issa K; Stevens MN; Sun Y; Thomas S; Collins A; Cohen J; Esclamado RM; Rocke DJ Ear Nose Throat J; 2022 Aug; 101(7):456-462. PubMed ID: 33090902 [TBL] [Abstract][Full Text] [Related]
18. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314 [TBL] [Abstract][Full Text] [Related]
19. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis. Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997 [TBL] [Abstract][Full Text] [Related]
20. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]